Skip to main content
. 2011 Nov;166(2):281–290. doi: 10.1111/j.1365-2249.2011.04471.x

Fig. 5.

Fig. 5

Interleukin (IL)-17 interfered with the insulin-signalling pathway in vitro. Representative autoradiographs of insulin pathway [insulin substrate receptor 1 (IRS-1) and protein kinase B (AKT) and fatty acid metabolism [sterol receptor element-binding protein-1c and peroxisome proliferator-activated receptor-α (SREBP-1c and PPAR-α)].